NC-LENOVO
28.8.2024 15:01:27 CEST | Business Wire | Press release
Lenovo (HKSE: 992) (ADR: LNVGY), the global technology powerhouse, is offering Lenovo Hybrid Cloud Advisory Services to help enterprises simplify the complexity of hybrid cloud design and create implementation-ready, future-proofed plans in as few as six weeks. Lenovo leverages four decades of experience helping global CIOs ease cloud and hybrid cloud challenges, including demands associated with emerging AI-related workloads. With the new services, Lenovo expert consultants guide enterprises through hybrid cloud needs, accelerating time to value, improving cost efficiency, and building flexibly scalable foundations.
The new era of AI is hybrid, and today’s IT organizations are converting their raw data into actionable insights with hybrid cloud solutions that are capable of harnessing data, no matter where it lives. Lenovo hybrid cloud solutions boost AI performance and agility by delivering more compute and faster memory when and where it’s needed, offering a full-stack portfolio and purpose-built solutions that are specific to each customer and use case. To support AI optimization, Lenovo Hybrid Cloud Advisory Services help design a cloud approach customized for today, and ready to flexibly scale and adapt to future needs.
“At a time when the need for modern infrastructure and solutions has never been greater, IT is challenged to evolve cloud implementations. This is evident in our most recent Lenovo global CIO report in which 82% of respondents marked cloud transformation as challenging,” said Dale Aultman, Vice President & General Manager, Hybrid Cloud Services at Lenovo Group. “We introduced Lenovo Hybrid Cloud Advisory Services to simplify cloud design strategies and pave the way for AI implementations. We bring a global team of trusted experts to help our customers develop future-proofed, tailor-made solutions to rapidly modernize hybrid clouds and ultimately deliver better business outcomes.”
Many organizations need to modernize or update their hybrid clouds due to changing business needs, spiraling costs, or performance issues. In fact, Lenovo’s third annual global CIO report found that 29% of respondents still find cloud transformation a top priority, behind AI implementation, cybersecurity, and data privacy. Demand for data center capacity continues to grow and, with increasing interest in AI, is also accelerating. IT leaders are concerned about meeting this demand due to challenges around qualified staff, procuring equipment, forecasting future requirements and energy efficiencies. Changing licensing models are also generating disruption and requiring IT leaders to lean on partners.
“Successful hybrid cloud strategy and design is imperative for enterprises, yet the underlying complexity involved cannot be understated,” said Steven Dickens, Futurum Group. “According to our research, hybrid is 2x the size of public cloud when it comes to deployment modalities for AI, therefore the need for flexibility and futureproofing becomes critical. Partnering with experts, such as Lenovo, will be the smart path forward for many enterprises.”
Lenovo Hybrid Cloud Advisory Services offers customized, strategic expertise, and a trusted partner to manage the complexity of hybrid cloud design. Lenovo experts help turn hybrid cloud vision into reality with better outcomes using customer assessment, proven methodologies, and strategic advice and approach recommendation. Lenovo’s tech-agnostic expertise, deep industry alliances and partnerships, pre-validated solutions, and experience in every aspect of hybrid cloud creation provide clear value while helping future-proof an organization’s hybrid cloud. Customer benefits include:
- Speed/Time to value
- Holistic: Cloud/software/infrastructure expertise from single provider
- End-to-end expertise
- Engineering quality
- Global presence
Lenovo Hybrid Cloud Advisory Services features a breadth of offerings that are now available, expanding Lenovo’s advisory services capabilities and complementing Lenovo’s AI services portfolio. Channel availability will launch in September 2024.
For more information regarding Lenovo Hybrid Cloud Advisory Services visit here.
About Lenovo
Lenovo is a US$57 billion revenue global technology powerhouse, ranked #248 in the Fortune Global 500, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver Smarter Technology for All, Lenovo has built on its success as the world’s largest PC company with a full-stack portfolio of AI-enabled, AI-ready, and AI-optimized devices (PCs, workstations, smartphones, tablets), infrastructure (data center, storage, edge, high performance computing and software defined infrastructure), software, solutions, and services. Lenovo’s continued investment in world-changing innovation is building a more equitable, trustworthy, and smarter future for everyone, everywhere. Lenovo is listed on the Hong Kong stock exchange under Lenovo Group Limited (HKSE: 992) (ADR: LNVGY). To find out more visit https://www.lenovo.com, and read about the latest news via our StoryHub.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240828812342/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom